Back to search

Article

Erchen Decoction regulates AMPK pathway in the treatment of metabolic syndrome induced by second-generation antipsychotics based on network pharmacology and molecular docking strategy

2023-05-01

Abstract excerpt

Erchen Decoction(ECD) has been clinically verified to be effective for treating metabolic syndrome(MetS) induced by second-generation antipsychotics(SGAs). Network pharmacology analysis results exhibited that 129 active components and 221 potential targets of ECD, 1027 targets related to MetS, and 361 targets of clozapine and olanzapine were gained after screening. Then, 79 intersection targets of ECD and MetS wer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6d5769a7-20c6-5c5b-8563-1e22f7e2b1ab
DOI
10.22541/au.168293190.09954050/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Erchen Decoction regulates AMPK pathway in the treatment of metabolic syndrome induced by second-generation antipsychotics based on network pharmacology and molecular docking strategyDOI 10.22541/au.168293190.09954050/v1
Erchen Decoction regulates AMPK pathway in the treatment of metabolic syndrome induced by second-generation antipsychotics based on network analysisSemantic proximity
Network Pharmacology Integrated Molecular Docking Reveals The Mechanism of Huanglian Wendan Decotion Against Metabolic SyndromeSemantic proximity
Network pharmacology-based strategy to investigate the molecular target and mechanism of Jiawei Linggui Zhugan decoction in the treatment of obesitySemantic proximity
Mechanistic Study of Yang-gan-jie-yu Granules in Treating Postmenopausal Metabolic-Associated Fatty Liver Disease Based on Transcriptomics and Network PharmacologySemantic proximity
Identify Key Active Ingredients and Molecular Mechanisms of Jiangzhi Decoction on Non-alcoholic Fatty Liver Disease by Network Pharmacology AnalysisSemantic proximity
Identifying genetic contributions of 6q21 loci and PPAR pathway to antipsychotic-induced metabolic syndrome: a Sex-Stratified Multi-Omics study.Semantic proximity
Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS).Semantic proximity
Explore of potential targets and mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experimentsSemantic proximity
Metformin pathwaysSemantic proximity
Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signaturesSemantic proximity
Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacologySemantic proximity
Exploring anti-nonalcoholic fatty liver disease mechanism of Gardeniae Fructus by combining an animal model with network pharmacology and molecular dockingSemantic proximity
Select a neighboring publication to make it the new centre.